iEngage Social Network Intervention for HIV/AIDS

N/A

Waitlist Available

Led By Tiarney Ritchwood, Ph.D.

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 month, and 12 month follow up

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a social network intervention to improve HIV-related outcomes for ALWH in South Africa.

Who is the study for?

This trial is for adolescents living with HIV in South Africa who are willing to let researchers access their clinic data, live in the study area, and can consent or bring a social network member to join the intervention.

What is being tested?

The 'iEngage' intervention is being tested to see if it improves retention in HIV care and antiretroviral therapy adherence among adolescents by leveraging social support within their networks.

What are the potential side effects?

Since 'iEngage' focuses on social support rather than medication, there may not be direct medical side effects. However, participants might experience emotional or psychological impacts from engaging with their social networks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 month, and 12 month follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 month, and 12 month follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 month, and 12 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability: exit interviews

Feasibility: exit interviews

Secondary study objectives

Change in ART adherence

Change in HIV knowledge

Change in HIV stigma & discrimination

+18 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: iEngageExperimental Treatment1 Intervention

The intervention is a network-based, social support intervention to improve ALWH retention in HIV care and ART adherence. The specific intervention will be developed during Aim 2 of the study and uses qualitative findings, along with data from Aim 1, to develop an interventions that integrates participant feedback and borrows components from two existing interventions

Do I qualify?Apply below to find out